Alterity Therapeutics Ltd Adr (ATHE)

Jul 29, 2025

ATHE: A Tale of Ups & Downs – 63.16% gain in 6 Months, 42.35% in 30 Days - investchronicle.com

Jul 29, 2025

Jul 14, 2025

SMCI’s Market Flip-Flop: Exploring the Volatility of 2025 Performance - investchronicle.com

Jul 14, 2025

Jun 23, 2025

Alterity CEO to provide corporate update on ATH434 development - Investing.com

Jun 23, 2025

May 12, 2025

Alterity Therapeutics highlighted at MSA Congress - Investing.com

May 12, 2025

May 12, 2025

Alterity Therapeutics highlighted at MSA Congress By Investing.com - Investing.com India

May 12, 2025

May 07, 2025

Alterity Therapeutics reports Phase 2 data at MSA Congress - Investing.com

May 07, 2025

May 07, 2025

Alterity Therapeutics reports Phase 2 data at MSA Congress By Investing.com - Investing.com South Africa

May 07, 2025

Apr 10, 2025

Alterity shares new phase 2 data on MSA treatment - Investing.com

Apr 10, 2025

Apr 07, 2025

Alterity Therapeutics announces regulatory notice - Investing.com

Apr 07, 2025

Apr 07, 2025

Alterity Therapeutics completes placement - Investing.com

Apr 07, 2025

Apr 07, 2025

Alterity Therapeutics announces regulatory notice By Investing.com - Investing.com UK

Apr 07, 2025

Apr 07, 2025

Alterity Therapeutics completes placement By Investing.com - Investing.com UK

Apr 07, 2025

Mar 27, 2025

ATHEAlterity Therapeutics Ltd Latest Stock News & Market Updates - Stock Titan

Mar 27, 2025

Mar 27, 2025

Alterity Concludes Open-Label Trial Patient Visits - Investing.com

Mar 27, 2025

Feb 18, 2025

Alterity Therapeutics announces compliance notice - Investing.com

Feb 18, 2025

Feb 10, 2025

Alterity secures funding to advance MSA drug development - Investing.com

Feb 10, 2025

Feb 06, 2025

Alterity Therapeutics announces trading halt - Investing.com

Feb 06, 2025

Feb 05, 2025

Alterity Therapeutics reports compliance with Takeovers Panel - Investing.com

Feb 05, 2025

Feb 04, 2025

Alterity Therapeutics announces securities notice - Investing.com

Feb 04, 2025

Jan 30, 2025

Alterity Therapeutics announces ATH434 Phase 2 trial results - TipRanks

Jan 30, 2025

Jan 24, 2025

Alterity Therapeutics reports quarterly activities - Investing.com

Jan 24, 2025

Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024

Dec 16, 2024

Most active stocks: US stocks with the highest trading volume today - Yahoo

Dec 16, 2024

Dec 04, 2024

ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns - Stockhead

Dec 04, 2024

Mar 06, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 06, 2024

Feb 15, 2024

Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners - Stockhead

Feb 15, 2024

Aug 17, 2023

Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead

Aug 17, 2023

Aug 03, 2023

Biotech Stocks: Longevity Company Stocks - Investing.com

Aug 03, 2023

Jan 06, 2023

Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) - PR Newswire

Jan 06, 2023

Jul 25, 2022

Biggest Stock LosersToday’s Biggest Percentage Decliners - MarketBeat

Jul 25, 2022

Jan 10, 2022

Alterity Therapeutics LtdADR Shares Close the Week 40.3% HigherWeekly Wrap - Nasdaq

Jan 10, 2022

Jan 30, 2019

Most Volatile Stocks, What Investors Need to Know - MarketBeat

Jan 30, 2019

Dec 10, 2017

A Full List of Australia ADRs - Investing.com Australia

Dec 10, 2017

Nov 24, 2017

How Investors Can Identify and Successfully Trade Gap-Down Stocks - MarketBeat

Nov 24, 2017

Nov 21, 2017

What Investors Need to Know to Beat the Market - MarketBeat

Nov 21, 2017

Nov 21, 2017

Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat

Nov 21, 2017